Pharmaceutical Engineers are key professionals in the pharmaceutical industry, responsible for designing, optimizing, and scaling up manufacturing processes to produce drugs efficiently and safely. They combine principles of engineering, chemistry, and biology to develop and improve the systems used for drug production, from small-scale laboratory experiments to full-scale industrial manufacturing. Their expertise ensures that production processes are efficient, cost-effective, and compliant with regulatory standards, ensuring high-quality products. They also focus on enhancing automation and integrating cutting-edge technologies like artificial intelligence and robotics to further optimize manufacturing processes. By improving energy efficiency and minimizing environmental impact, pharmaceutical engineers contribute to more sustainable manufacturing practices.
These engineers are involved in the design and operation of equipment for formulation, packaging, and quality control, as well as in the development of new technologies for drug delivery and production. They play a vital role in ensuring that pharmaceutical products are manufactured under sterile conditions, meet all quality standards, and are produced consistently. By optimizing production workflows, pharmaceutical engineers contribute to the sustainable and reliable supply of drugs, making sure that critical medications reach patients without delay. Their work is essential for improving manufacturing techniques, reducing waste, and ensuring the safety of pharmaceutical products on a global scale.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia